Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 6434 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 9376 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 14684 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 21907 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 22827 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 33408 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 34118 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 44060 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 44447 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 45421 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 45644 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 48912 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 48963 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 50789 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 56008 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 60106 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 63795 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 70263 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 70271 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 78382 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 100511 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 112274 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 113217 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 147279 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | 155012 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | CITRAMALIC ACID (M-H)- | Peak area normalized | female | Pre-diabetic | Neuropathy |